Advertisement

Migraine

The prevalence of migraine in Argentina: A reappraisal.

Feb 04, 2021

Argentina has one of the largest territories in the world, which spreads over a lengthy latitudinal span. Its population is mainly composed of a mixture of South American natives and the descendants o...

Underuse of Behavioral Treatments for Headache: a Narrative Review Examining Societal and Cultural Factors.

Feb 04, 2021

Migraine affects over 40 million Americans and is the world's second most disabling condition. As the majority of medical care for migraine occurs in primary care settings, not in neurology nor headac...

Effectiveness of ketogenic diet in treatment of patients with refractory chronic migraine.

Feb 04, 2021

Ketogenic diet (KD) is based on restriction of carbohydrate intake. Metabolism is forced to obtain energy starting from β-oxidation of fatty acids which, turned into ketone bodies, can also be used b...

Changes in headache characteristics with oral appliance treatment for obstructive sleep apnea.

Feb 01, 2021

Changes in headache characteristics in obstructive sleep apnea (OSA) patients following oral appliance treatment was investigated for the first time. Thirteen OSA patients with headaches treated with ...

Prevalence and characteristics of cutaneous allodynia in probable migraine.

Feb 01, 2021

Cutaneous allodynia (CA) is a pain in response to non-nociceptive stimulation and a marker of central sensitisation. Probable migraine (PM) is a migraine subtype that fulfils all but one criterion of ...

Thalamocortical Connectivity in Experimentally-Induced Migraine Attacks: A Pilot Study.

Feb 01, 2021

In this study we used nitroglycerin (NTG)-induced migraine attacks as a translational human disease model. Static and dynamic functional connectivity (FC) analyses were applied to study the associated...

Prevalence, Disability, and Management Patterns of Migraine in Korea: Nationwide Survey Data from 2009 and 2018.

Jan 28, 2021

Identifying changes in the prevalence, disability, and management patterns of migraine is important for reducing the burden of this disease. However, data on the changes in these variables are scarce....

Psychometric validation and meaningful within-patient change of the Migraine-Specific Quality of Life questionnaire version 2.1 electronic patient-reported outcome in patients with episodic and chronic migraine.

Jan 28, 2021

To evaluate the measurement properties of all three domains of the Migraine-Specific Quality of Life questionnaire version 2.1 (MSQ v2.1) electronic patient-reported outcome (ePRO) to assess the funct...

Introduction of a smartphone based behavioral intervention for migraine in the emergency department.

Jan 28, 2021

To determine whether a smartphone application (app) with an electronic headache diary and a progressive muscle relaxation (PMR) intervention is feasible and acceptable to people presenting to the Emer...

Natural History and Conservative Treatment Options in Chiari Malformation Type I in Adults: A Literature Update.

Jan 18, 2021

Over the years, knowledge regarding the natural history of Chiari malformation type I (CM-I) has improved. However, there are still uncertainties in the literature regarding asymptomatic and oligosymp...

The Effect of Psychiatric Comorbidities on Headache-Related Disability in Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.

Jan 18, 2021

To examine the influences of depression and anxiety on headache-related disability in people with episodic migraine or chronic migraine.Depression and anxiety are common comorbidities in people with m...

The Efficacy of Vitamin D Supplementation for Migraine: A Meta-Analysis of Randomized Controlled Studies.

Jan 18, 2021

The efficacy of vitamin D for migraine remains controversial. We conduct a systematic review and meta-analysis to explore the influence of vitamin D versus placebo on treatment in migraine patients.We...

Headache Characteristics and Psychological Factors Associated with Functional Impairment in Individuals with Persistent Posttraumatic Headache.

Jan 14, 2021

Persistent posttraumatic headache (PPTH), one of the most common symptoms following mild traumatic brain injury, is often associated with substantial functional disability. The objective of this study...

Headache characteristics and burden from chronic migraine with medication overuse headache: Cross-sectional observations from the Medication Overuse Treatment Strategy trial.

Jan 14, 2021

To describe headache characteristics, medication use, disability, and quality of life in a large patient cohort from the United States who have chronic migraine (CM) and medication overuse headache (M...

Management of primary headaches during pregnancy, postpartum, and breastfeeding: A systematic review.

Jan 14, 2021

Primary headaches (migraine, tension headache, cluster headache, and other trigeminal autonomic cephalgias) are common in pregnancy and postpartum. It is unclear how to best and most safely manage the...

Headache during SARS-CoV-2 infection as an early symptom associated with a more benign course of disease: a case-control study.

Jan 11, 2021

Headache is an important manifestation during SARS-CoV-2 infection. In this study, we aim to identify factors associated with headache in COVID-19 and headache characteristics.This case-control study ...

Laterality judgements in patients with frequent episodic migraine.

Jan 11, 2021

Migraine is a cyclic disorder but also a chronic pain condition. Left-right recognition tasks have been shown to be impaired in patients with chronic pain.To investigate whether laterality judgements ...

Evaluation of the 6-item Identify Chronic Migraine screener in a large medical group.

Jan 11, 2021

To evaluate the sensitivity and specificity of the 6-item Identify Chronic Migraine screener (ID-CM[6]), designed to improve the detection of chronic migraine (CM).CM is often undertreated and underdi...

Characteristics of pain in patients with pituitary adenomas: a cross-sectional study.

Jan 07, 2021

This study determines the prevalence and particularities of headache and pain with neuropathic characteristics (NC) in a large French group of patients with pituitary adenoma (PA).Analysis of validate...

Long-term efficacy and safety of erenumab in migraine prevention: results from a 5-year, open-label treatment phase of a randomized clinical trial.

Jan 07, 2021

Although erenumab has demonstrated significant reduction in migraine frequency and improved quality of life in studies lasting 3-12 months, little is known about long-term therapy.Open-label, 5-year t...